---
title: "Baird Medical (BDMD) files late-filing notice for its 2024 annual report"
url: "https://aibio.space/news/baird-medical-bdmd-files-late-filing-notice-2024-annual-report/"
event_date: "2025-04-30"
date_published: "2026-11-08"
description: "Baird Medical Investment Holdings Limited filed a Form 12b-25 notice on April 30, 2025, saying its 2024 Form 20-F could not be filed on time. The company changed auditors earlier that year."
---

# Baird Medical (BDMD) files late-filing notice for its 2024 annual report

Baird Medical Investment Holdings Limited (Nasdaq: BDMD) filed a [Notification of Late Filing on Form 12b-25](https://www.sec.gov/Archives/edgar/data/1982444/000110465925042627/0001104659-25-042627.txt) on April 30, 2025. The form covers the annual report on Form 20-F for the period ended December 31, 2024. The box checked on the form says the report could not be filed without unreasonable effort or expense. The signature block is dated April 30, 2024, not 2025.

Why is this important: A late annual report is a warning sign, because it can mean the audit or the accounting work is not finished. The notice cites the need for more time to prepare and review the consolidated financial statements. For holders, the question is whether the company and its new auditor could deliver the report on time after an auditor change earlier that year. An [EDGAR filing list](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1982444&type=20-F&dateb=&owner=include&count=40) shows a Form 20-F filed May 15, 2025, inside the 15-day extension the notice cited.

Haimei Wu, the chairwoman and chief executive officer, signed the notice and is its contact. The board and its audit committee approved and ratified the dismissal of Marcum Asia CPAs LLP as the company's independent registered public accounting firm, effective January 24, 2025, and appointed Kreit & Chiu CPA LLP, according to a [Form 6-K filed January 28, 2025](https://www.sec.gov/Archives/edgar/data/1982444/000110465925006483/0001104659-25-006483.txt). In our view, a late annual report that follows an auditor change calls for a plain account of what slowed the work. The notice gives only a general reason, the need for more time, and does not say whether the auditor change caused the delay.

## What the notice says

The notice invokes the late-filing relief in Rule 12b-25 for the 20-F. It says the company expects to file the report within the 15-day extension period prescribed by Rule 12b-25(b)(2)(ii). The company's address on the form is in Guangzhou, People's Republic of China, and Haimei Wu is the contact. The form says the company does not expect a significant change in results from the prior year, and the notice carries no financial figures.

## The business behind the report

The company's [Form F-1/A filed January 17, 2025](https://www.sec.gov/Archives/edgar/data/1982444/000110465925004489/0001104659-25-004489.txt) describes Baird Medical as one of the leading microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its devices are used for benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The company says it ranked first among microwave ablation medical device providers in treating thyroid nodules and breast lumps in the PRC, in sales revenue and sales volume, in 2022. That is the company's own claim. The prospectus gives net income of $12.8 million for 2022 and $10.7 million for 2023.

The prospectus warns that the company's high gross profit margin may not be sustainable, and that competition in the microwave ablation market in China has intensified. Warrants at an exercise price of $11.50 were issued on October 1, 2024, in exchange for the public warrants of ExcelFin Acquisition Corp. The prospectus names Puglisi & Associates as the company's agent for service of process in the United States.

## Auditor change and the 20-F deadline

The 6-K names Kreit & Chiu CPA LLP as the new auditor for the year ended December 31, 2024, the period the late notice covers. Marcum Asia's reports on the 2023 and 2022 financial statements contained no adverse opinion or disclaimers of opinion. The 6-K says the company gave Marcum Asia a copy of the disclosure and asked for a letter to the SEC, which is filed as Exhibit 16.1. The same 6-K says the company had material weaknesses in internal control over financial reporting, including a lack of sufficient financial reporting and accounting personnel with knowledge of U.S. GAAP and SEC reporting requirements, and a lack of a comprehensive accounting policies and procedures manual. The notice followed on April 30, 2025. EDGAR lists the Form 20-F as filed May 15, 2025.

Sources

- https://www.sec.gov/Archives/edgar/data/1982444/000110465925042627/0001104659-25-042627.txt
- https://www.sec.gov/Archives/edgar/data/1982444/000110465925006483/0001104659-25-006483.txt
- https://www.sec.gov/Archives/edgar/data/1982444/000110465925004489/0001104659-25-004489.txt
- https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1982444&type=20-F&dateb=&owner=include&count=40
